Press Release – New York, NY – April 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on …
Sichenzia Ross Ference Carmel LLP Represents Alternus Clean Energy, Inc. in a $2.16 Million Private Placement
New York, NY - April 24, 2024 - Sichenzia Ross Ference Carmel LLP announced that it has represented Alternus Clean Energy, Inc. (NASDAQ: ALCE) (“Alternus” or the “Company”), a transatlantic clean …
Sichenzia Ross Ference Carmel LLP Represents Genetic Technologies Limited in a $2 Million Registered Direct Offering and Concurrent Private Placement
New York, NY – April 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”) in a $2 million registered direct …
Sichenzia Ross Ference Carmel LLP Represents Craft Capital Management LLC and R.F. Lafferty & Co. in a $4.2 Million Initial Public Offering and Nasdaq Listing of Mingteng International Corporation
New York, NY - April 22, 2024 - Sichenzia Ross Ference Carmel LLP (SRFC) today announced that it represented Craft Capital Management LLC and R.F. Lafferty & Co. in an initial public offering of …
Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in a $2 Million Common Stock Offering of NRx Pharmaceuticals, Inc.
New York, NY - April 22, 2024 - Sichenzia Ross Ference Carmel LLP (SRFC) announced that it represented EF Hutton LLC as the sole book-runner in a public offering of NRx Pharmaceuticals, Inc. ("NRx …
Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $40 Million Common Stock Offering and Nasdaq Uplisting of Serve Robotics Inc.
New York, NY - April 22, 2024 - Sichenzia Ross Ference Carmel LLP announced today that it represented Aegis Capital Corp, as the sole book-running manager in a common stock offering and uplisting to …
